Trastuzumab Emtansine
Generic Name: trastuzumab emtansine
Dosage form: LIQUID. Active ingredients: TRASTUZUMAB EMTANSINE (20 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: TRASTUZUMAB EMTANSINE (20 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Daratumumab And Hyaluronidase-fihj (human Recombinant)
daratumumab and hyaluronidase-fihj (human recombinant)
CD38-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody that binds to the CD38 antigen. Daratumumab is produced in Chinese Hamster Ovary (CHO) cells using recombinant DNA technology. The molecular weight of daratumumab is approximately 148 kDa. Hyaluronidase (recombinant human) is an endoglycosidase used to increase the dispersion and absorption of co-administered drugs when administered subcutaneously.
Diphenhydramine Hydrochloride, Brompheniramine Maleate, And Dextromethorphan Hydrobromide
diphenhydramine hydrochloride, brompheniramine maleate, and dextromethorphan hydrobromide
Active ingredient (in each 10 mL) Purpose Diphenhydramine HCl, 12.5 mg Antihistamine/cough suppressant
Acetaminophen, Caffeine, Pyrilamine Maleate
acetaminophen, caffeine, pyrilamine maleate
Central Nervous System Stimulant [EPC]
Uses for the temporary relief of these symptoms associated with menstrual periods: bloating headache muscle aches cramps backache fatigue water-weight gain
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.